How much did OPKO Health achieve in EBIT for the current year?
In the current year, OPKO Health has achieved an EBIT of -194.79 M USD.
OPKO Health EBIT 2025
OPKO Health EBIT
-194.79 M USD
Ticker
OPK
ISIN
US68375N1037
WKN
A0MUUJ
In 2025, OPKO Health's EBIT was -194.79 M USD, a 4.11% increase from the -187.1 M USD EBIT recorded in the previous year.
The OPKO Health EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2026e | -73.8 |
| 2025e | -194.79 |
| 2024e | -187.1 |
| 2023 | -157.02 |
| 2022 | -244.9 |
| 2021 | -12.7 |
| 2020 | 58.7 |
| 2019 | -178.7 |
| 2018 | -144.5 |
| 2017 | -257.4 |
| 2016 | -87.7 |
| 2015 | -98.5 |
| 2014 | -145.8 |
| 2013 | -79.6 |
| 2012 | -37.3 |
| 2011 | -23.2 |
| 2010 | -11.1 |
| 2009 | -20.1 |
| 2008 | -37.2 |
| 2007 | -23.4 |
| 2006 | -1.1 |
| 2005 | -1.4 |
| 2004 | -2.1 |
OPKO Health Revenue, EBIT, Net Income US68375N1037 · A0MUUJ
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into OPKO Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OPKO Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OPKO Health’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of OPKO Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into OPKO Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing OPKO Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OPKO Health’s growth potential.
OPKO Health Revenue, EBIT and net profit per share
| Date | OPKO Health Revenue | OPKO Health EBIT | OPKO Health Net Income |
|---|---|---|---|
| 2026e | 741.46 M undefined | -73.8 M undefined | -75.82 M undefined |
| 2025e | 691.77 M undefined | -194.79 M undefined | -198.75 M undefined |
| 2024e | 691.76 M undefined | -187.1 M undefined | -126.83 M undefined |
| 2023 | 863.5 M undefined | -157.02 M undefined | -188.86 M undefined |
| 2022 | 1 B undefined | -244.9 M undefined | -328.4 M undefined |
| 2021 | 1.77 B undefined | -12.7 M undefined | -30.1 M undefined |
| 2020 | 1.44 B undefined | 58.7 M undefined | 30.6 M undefined |
| 2019 | 901.9 M undefined | -178.7 M undefined | -314.9 M undefined |
| 2018 | 990.3 M undefined | -144.5 M undefined | -153 M undefined |
| 2017 | 966 M undefined | -257.4 M undefined | -305.3 M undefined |
| 2016 | 1.12 B undefined | -87.7 M undefined | -48.4 M undefined |
| 2015 | 491.7 M undefined | -98.5 M undefined | -30 M undefined |
| 2014 | 91.1 M undefined | -145.8 M undefined | -171.7 M undefined |
| 2013 | 96.5 M undefined | -79.6 M undefined | -114.8 M undefined |
| 2012 | 47 M undefined | -37.3 M undefined | -31.3 M undefined |
| 2011 | 28 M undefined | -23.2 M undefined | -3.7 M undefined |
| 2010 | 28.5 M undefined | -11.1 M undefined | -21.6 M undefined |
| 2009 | 4.4 M undefined | -20.1 M undefined | -34.8 M undefined |
| 2008 | 9.4 M undefined | -37.2 M undefined | -40.1 M undefined |
| 2007 | 800,000 undefined | -23.4 M undefined | -268.6 M undefined |
| 2006 | 0 undefined | -1.1 M undefined | -900,000 undefined |
| 2005 | 0 undefined | -1.4 M undefined | -400,000 undefined |
| 2004 | 0 undefined | -2.1 M undefined | -2.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 0 USD | -2.1 M USD | -2.1 M USD |
| 2005 | 0 USD | -1.4 M USD | -400,000 USD |
| 2006 | 0 USD | -1.1 M USD | -900,000 USD |
| 2007 | 800,000 USD | -23.4 M USD | -268.6 M USD |
| 2008 | 9.4 M USD | -37.2 M USD | -40.1 M USD |
| 2009 | 4.4 M USD | -20.1 M USD | -34.8 M USD |
| 2010 | 28.5 M USD | -11.1 M USD | -21.6 M USD |
| 2011 | 28 M USD | -23.2 M USD | -3.7 M USD |
| 2012 | 47 M USD | -37.3 M USD | -31.3 M USD |
| 2013 | 96.5 M USD | -79.6 M USD | -114.8 M USD |
| 2014 | 91.1 M USD | -145.8 M USD | -171.7 M USD |
| 2015 | 491.7 M USD | -98.5 M USD | -30 M USD |
| 2016 | 1.12 B USD | -87.7 M USD | -48.4 M USD |
| 2017 | 966 M USD | -257.4 M USD | -305.3 M USD |
| 2018 | 990.3 M USD | -144.5 M USD | -153 M USD |
| 2019 | 901.9 M USD | -178.7 M USD | -314.9 M USD |
| 2020 | 1.44 B USD | 58.7 M USD | 30.6 M USD |
| 2021 | 1.77 B USD | -12.7 M USD | -30.1 M USD |
| 2022 | 1 B USD | -244.9 M USD | -328.4 M USD |
| 2023 | 863.5 M USD | -157.02 M USD | -188.86 M USD |
| 2024e | 691.76 M USD | -187.1 M USD | -126.83 M USD |
| 2025e | 691.77 M USD | -194.79 M USD | -198.75 M USD |
| 2026e | 741.46 M USD | -73.8 M USD | -75.82 M USD |
OPKO Health stock margins US68375N1037 · A0MUUJ
The OPKO Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OPKO Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OPKO Health.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the OPKO Health's sales revenue. A higher gross margin percentage indicates that the OPKO Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the OPKO Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the OPKO Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OPKO Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OPKO Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OPKO Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
OPKO Health Margin History
| OPKO Health Gross margin | OPKO Health Profit margin | OPKO Health EBIT margin | OPKO Health Profit margin |
|---|---|---|---|
| 2026e | 36.84 % | -9.95 % | -10.23 % |
| 2025e | 36.84 % | -28.16 % | -28.73 % |
| 2024e | 36.84 % | -27.05 % | -18.33 % |
| 2023 | 36.84 % | -18.18 % | -21.87 % |
| 2022 | 28.7 % | -24.39 % | -32.7 % |
| 2021 | 32.77 % | -0.72 % | -1.7 % |
| 2020 | 37.69 % | 4.09 % | 2.13 % |
| 2019 | 36.53 % | -19.81 % | -34.92 % |
| 2018 | 38.94 % | -14.59 % | -15.45 % |
| 2017 | 35.81 % | -26.65 % | -31.6 % |
| 2016 | 45.28 % | -7.85 % | -4.33 % |
| 2015 | 52.17 % | -20.03 % | -6.1 % |
| 2014 | 47.31 % | -160.04 % | -188.47 % |
| 2013 | 49.43 % | -82.49 % | -118.96 % |
| 2012 | 40.85 % | -79.36 % | -66.6 % |
| 2011 | 38.21 % | -82.86 % | -13.21 % |
| 2010 | 52.63 % | -38.95 % | -75.79 % |
| 2009 | 34.09 % | -456.82 % | -790.91 % |
| 2008 | 9.57 % | -395.74 % | -426.6 % |
| 2007 | 36.84 % | -2,925 % | -33,575 % |
| 2006 | 36.84 % | 0 % | 0 % |
| 2005 | 36.84 % | 0 % | 0 % |
| 2004 | 36.84 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 36.84 % | 0 % | 0 % |
| 2005 | 36.84 % | 0 % | 0 % |
| 2006 | 36.84 % | 0 % | 0 % |
| 2007 | 36.84 % | -2,925 % | -33,575 % |
| 2008 | 9.57 % | -395.74 % | -426.6 % |
| 2009 | 34.09 % | -456.82 % | -790.91 % |
| 2010 | 52.63 % | -38.95 % | -75.79 % |
| 2011 | 38.21 % | -82.86 % | -13.21 % |
| 2012 | 40.85 % | -79.36 % | -66.6 % |
| 2013 | 49.43 % | -82.49 % | -118.96 % |
| 2014 | 47.31 % | -160.04 % | -188.47 % |
| 2015 | 52.17 % | -20.03 % | -6.1 % |
| 2016 | 45.28 % | -7.85 % | -4.33 % |
| 2017 | 35.81 % | -26.65 % | -31.6 % |
| 2018 | 38.94 % | -14.59 % | -15.45 % |
| 2019 | 36.53 % | -19.81 % | -34.92 % |
| 2020 | 37.69 % | 4.09 % | 2.13 % |
| 2021 | 32.77 % | -0.72 % | -1.7 % |
| 2022 | 28.7 % | -24.39 % | -32.7 % |
| 2023 | 36.84 % | -18.18 % | -21.87 % |
| 2024e | 36.84 % | -27.05 % | -18.33 % |
| 2025e | 36.84 % | -28.16 % | -28.73 % |
| 2026e | 36.84 % | -9.95 % | -10.23 % |
OPKO Health Aktienanalyse
What does OPKO Health do?
OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing OPKO Health's EBIT
OPKO Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of OPKO Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
OPKO Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in OPKO Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about OPKO Health stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company OPKO Health.
How has the EBIT of OPKO Health developed in recent years?
The EBIT of OPKO Health has increased by 4.112% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company OPKO Health?
The EBIT of OPKO Health is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does OPKO Health pay?
Over the past 12 months, OPKO Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OPKO Health is expected to pay a dividend of 0 USD.
What is the dividend yield of OPKO Health?
The current dividend yield of OPKO Health is .
When does OPKO Health pay dividends?
OPKO Health pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OPKO Health?
OPKO Health paid dividends every year for the past 0 years.
What is the dividend of OPKO Health?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OPKO Health located?
OPKO Health is assigned to the 'Health' sector.
Wann musste ich die Aktien von OPKO Health kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OPKO Health from 1/24/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/24/2025.
When did OPKO Health pay the last dividend?
The last dividend was paid out on 1/24/2025.
What was the dividend of OPKO Health in the year 2024?
In the year 2024, OPKO Health distributed 0 USD as dividends.
In which currency does OPKO Health pay out the dividend?
The dividends of OPKO Health are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The OPKO Health stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von OPKO Health
Our stock analysis for OPKO Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OPKO Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
